Skip to main content

CloudHealth Genomics Launches Liquid Biopsy for Very Early China Screening

Shanghai's CloudHealth Genomics has launched HealthySeq, a whole genome next generation sequencing (NGS)-based liquid biopsy for healthy individuals. The test establishes a genomic baseline when a person is healthy, facilitating early diagnosis for cancer in later life. Using the results, doctors can stratify the patients for predisposition to disease, screen them regularly and identify the most effective precision therapies. More details.... Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.